Skip to main content
. Author manuscript; available in PMC: 2019 Apr 1.
Published in final edited form as: Lancet Respir Med. 2017 Dec 19;6(4):276–286. doi: 10.1016/S2213-2600(17)30497-6

Figure 3. Tuberculosis-related outcomes* in children screened following the WHO symptom-based approach for the management of child contacts, stratified by the age of the child†.

Figure 3

*Individuals with coprevalent disease were excluded from analyses of incident disease. In this figure, tuberculosis-free indicates contacts free from tuberculosis, but these contacts might have had tuberculosis infection. Percentages might not total 100% because within-characteristic percentages were rounded to the nearest integer. †Participants were included in the pragmatic guideline if they had one tuberculosis-related symptom including chronic cough, fever, night sweats, haemoptysis, weight loss, and loss of appetite. Chronic cough was defined as a continuous, non-remitting cough present for >3 weeks. Fever was defined as body temperature of >38°C for 14 days, after exclusion of common causes such as malaria or pneumonia. Weight loss was defined as reporting of weight loss or failure to thrive with confirmatory evidence from the child’s growth chart. Haemoptysis was defined as the expectoration of blood from the lung airways or parenchyma. Night sweats and loss of appetite were self-reported by children and parents. Asymptomatic contacts included children with cough of <3 weeks’ duration or fever of <2 weeks’ duration, or both. The difference between coprevalent tuberculosis among symptomatic and asymptomatic contacts was statistically different for children younger than 5 years (33% vs 6%, p<0.0001) and aged 5 years or older (10% vs 2%, p<0.0001).